These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35605649)

  • 21. Transcript- and tissue-specific imprinting of a tumour suppressor gene.
    Schulz R; McCole RB; Woodfine K; Wood AJ; Chahal M; Monk D; Moore GE; Oakey RJ
    Hum Mol Genet; 2009 Jan; 18(1):118-27. PubMed ID: 18836209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolutionarily conserved human targets of adenosine to inosine RNA editing.
    Levanon EY; Hallegger M; Kinar Y; Shemesh R; Djinovic-Carugo K; Rechavi G; Jantsch MF; Eisenberg E
    Nucleic Acids Res; 2005; 33(4):1162-8. PubMed ID: 15731336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors.
    Kohlmeyer JL; Kaemmer CA; Pulliam C; Maharjan CK; Samayoa AM; Major HJ; Cornick KE; Knepper-Adrian V; Khanna R; Sieren JC; Leidinger MR; Meyerholz DK; Zamba KD; Weimer JM; Dodd RD; Darbro BW; Tanas MR; Quelle DE
    Clin Cancer Res; 2020 Jun; 26(12):2997-3011. PubMed ID: 32086342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HERC3 directly targets RPL23A for ubiquitination degradation and further regulates Colorectal Cancer proliferation and the cell cycle.
    Zhang Z; Wu Q; Fang M; Liu Y; Jiang J; Feng Q; Hu R; Xu J
    Int J Biol Sci; 2022; 18(8):3282-3297. PubMed ID: 35637966
    [No Abstract]   [Full Text] [Related]  

  • 25. ECRG4 as a novel tumor suppressor gene inhibits colorectal cancer cell growth in vitro and in vivo.
    Cai Z; Liang P; Xuan J; Wan J; Guo H
    Tumour Biol; 2016 Jul; 37(7):9111-20. PubMed ID: 26762416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional analysis of bladder cancer-related protein gene: a putative cervical cancer tumor suppressor gene in cervical carcinoma.
    Zuo Z; Zhao M; Liu J; Gao G; Wu X
    Tumour Biol; 2006; 27(4):221-6. PubMed ID: 16675915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis.
    Song Y; An O; Ren X; Chan THM; Tay DJT; Tang SJ; Han J; Hong H; Ng VHE; Ke X; Shen H; Pitcheshwar P; Lin JS; Leong KW; Molias FB; Yang H; Kappei D; Chen L
    J Hepatol; 2021 Jan; 74(1):135-147. PubMed ID: 32693003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered adenosine-to-inosine RNA editing in human cancer.
    Paz N; Levanon EY; Amariglio N; Heimberger AB; Ram Z; Constantini S; Barbash ZS; Adamsky K; Safran M; Hirschberg A; Krupsky M; Ben-Dov I; Cazacu S; Mikkelsen T; Brodie C; Eisenberg E; Rechavi G
    Genome Res; 2007 Nov; 17(11):1586-95. PubMed ID: 17908822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine-to-Inosine RNA Editing in Health and Disease.
    Gatsiou A; Vlachogiannis N; Lunella FF; Sachse M; Stellos K
    Antioxid Redox Signal; 2018 Sep; 29(9):846-863. PubMed ID: 28762759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A-to-I RNA editing and cancer: from pathology to basic science.
    Gallo A; Galardi S
    RNA Biol; 2008; 5(3):135-9. PubMed ID: 18758244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.
    Ramírez-Moya J; Baker AR; Slack FJ; Santisteban P
    Oncogene; 2020 Apr; 39(18):3738-3753. PubMed ID: 32157211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-181a promotes growth of thyroid cancer cells by targeting tumor suppressor RB1.
    Le F; Luo P; Yang QO; Zhong XM
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5638-5647. PubMed ID: 29271997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RB1: a prototype tumor suppressor and an enigma.
    Dyson NJ
    Genes Dev; 2016 Jul; 30(13):1492-502. PubMed ID: 27401552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADAR1 Transcriptome editing promotes breast cancer progression through the regulation of cell cycle and DNA damage response.
    Sagredo EA; Sagredo AI; Blanco A; Rojas De Santiago P; Rivas S; Assar R; Pérez P; Marcelain K; Armisén R
    Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118716. PubMed ID: 32275931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bidirectional transcription of Linc00441 and RB1 via H3K27 modification-dependent way promotes hepatocellular carcinoma.
    Tang J; Xie Y; Xu X; Yin Y; Jiang R; Deng L; Tan Z; Gangarapu V; Tang J; Sun B
    Cell Death Dis; 2017 Mar; 8(3):e2675. PubMed ID: 28300839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
    Fritzell K; Xu LD; Lagergren J; Öhman M
    Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine-to-inosine RNA editing.
    Zinshteyn B; Nishikura K
    Wiley Interdiscip Rev Syst Biol Med; 2009; 1(2):202-209. PubMed ID: 20835992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conservation of A-to-I RNA editing in bowhead whale and pig.
    Larsen K; Heide-Jørgensen MP
    PLoS One; 2021; 16(12):e0260081. PubMed ID: 34882682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular alterations in retinoblastoma beyond RB1.
    Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
    Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulated miR-9-3p Promotes Cell Growth and Inhibits Apoptosis in Medullary Thyroid Carcinoma by Targeting BLCAP.
    Chen Y; Zhang S; Zhao R; Zhao Q; Zhang T
    Oncol Res; 2017 Sep; 25(8):1215-1222. PubMed ID: 27938505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.